← SynDRA
PAXALISIB
SynDRA canonical compound SYN0038562 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MTOR | PIK3CA | PIK3CB | PIK3CD | PIK3CG |
|---|
| Mechanism of action | mTOR inhibitor | PI3K inhibitor |
|---|
All known targets
- MTOR
- PIK3CA
- PIK3CG
- PIK3CB
- PIK3CD
Mechanisms of action (all sources)
- MTOR inhibitor
- PIK3CA INHIBITOR
- PI3K inhibitor
- PIK3CG INHIBITOR
Drug classes
Cross-references
Synonyms
- RG 7666
- Sim-0395
- G-02441729
- G02441729
- GDC-0084
- GDC0084
- GDC-0084/RG7666
- GDC 0084
- P5DKZ70636
- RG-7666
- RefChem:928638
- PI3K Inhibitor GDC-0084
- Paxalisib [USAN]
- PAXALISIB (GDC-0084)
- SIM-0395
- C18H22N8O2
- MFCD30187522
- Paxalisib [WHO-DD]
- PAXALISIB [INN]
- Paxalisib (USAN/INN)
- Paxalisib (GDC-0084)?
- UNII-P5DKZ70636
- orb1303870
- SCHEMBL10239943
- SCHEMBL29369326
- GTPL10097
- GLXC-90500
- EX-A1019
- GDC-0084RG7666
- BDBM50177662
- NSC792987
- s8163
- WHO 11102
- AKOS030526470
- CCG-268430
- CS-5638
- EBC-220112
- NSC-792987
- SB19742
Look up PAXALISIB in the interactive SynDRA portal →